LT4483956T - Troriluzolo panaudojimas spinocerebralinės ataksijos 3 (sca3) gydymui - Google Patents

Troriluzolo panaudojimas spinocerebralinės ataksijos 3 (sca3) gydymui

Info

Publication number
LT4483956T
LT4483956T LTEP24199849.1T LT24199849T LT4483956T LT 4483956 T LT4483956 T LT 4483956T LT 24199849 T LT24199849 T LT 24199849T LT 4483956 T LT4483956 T LT 4483956T
Authority
LT
Lithuania
Prior art keywords
troriluzole
sca3
treatment
spinocerebellar ataxia
spinocerebellar
Prior art date
Application number
LTEP24199849.1T
Other languages
English (en)
Inventor
Vladimir Coric
Robert Berman
Melissa BEINER
Gilbert L'ITALIEN
Original Assignee
Biohaven Therapeutics Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66438598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT4483956(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biohaven Therapeutics Ltd. filed Critical Biohaven Therapeutics Ltd.
Publication of LT4483956T publication Critical patent/LT4483956T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEP24199849.1T 2017-11-12 2018-11-11 Troriluzolo panaudojimas spinocerebralinės ataksijos 3 (sca3) gydymui LT4483956T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762584856P 2017-11-12 2017-11-12
US201862717948P 2018-08-13 2018-08-13

Publications (1)

Publication Number Publication Date
LT4483956T true LT4483956T (lt) 2026-04-27

Family

ID=66438598

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP24199849.1T LT4483956T (lt) 2017-11-12 2018-11-11 Troriluzolo panaudojimas spinocerebralinės ataksijos 3 (sca3) gydymui
LTEPPCT/US2018/060232T LT3706739T (lt) 2017-11-12 2018-11-11 Riluzolo provaisto naudojimas ataksijų gydymui

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2018/060232T LT3706739T (lt) 2017-11-12 2018-11-11 Riluzolo provaisto naudojimas ataksijų gydymui

Country Status (26)

Country Link
US (3) US20210023061A1 (lt)
EP (4) EP4483956B1 (lt)
JP (2) JP7352542B2 (lt)
KR (2) KR20200103658A (lt)
CN (1) CN112292127A (lt)
AU (1) AU2018364749C1 (lt)
BR (1) BR112020009173A2 (lt)
CA (1) CA3082096A1 (lt)
DK (2) DK3706739T3 (lt)
ES (1) ES2996892T3 (lt)
FI (2) FI4483956T3 (lt)
HR (1) HRP20241675T1 (lt)
HU (1) HUE070302T2 (lt)
IL (1) IL274532B2 (lt)
LT (2) LT4483956T (lt)
MD (1) MD3706739T2 (lt)
MX (2) MX2020004678A (lt)
PH (1) PH12020550583A1 (lt)
PL (1) PL3706739T3 (lt)
PT (2) PT3706739T (lt)
RS (2) RS66277B1 (lt)
SG (1) SG11202004332XA (lt)
SI (1) SI3706739T1 (lt)
SM (2) SMT202500022T1 (lt)
WO (1) WO2019094851A1 (lt)
ZA (1) ZA202002626B (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10639298B2 (en) 2015-03-03 2020-05-05 Biohaven Therapeutics Ltd. Prodrugs of riluzole and their method of use
US12295942B2 (en) 2015-03-03 2025-05-13 Biohaven Therapeutics Ltd. Riluzole prodrugs and their use
US12029731B2 (en) 2016-08-10 2024-07-09 Biohaven Therapeutics Ltd. Acyl benzo[d]thiazol-2-amine and their methods of use
WO2022155564A1 (en) * 2021-01-18 2022-07-21 Biohaven Therapeutics Ltd. Use of riluzole prodrugs to treat alzheimer's disease
WO2023081860A1 (en) * 2021-11-04 2023-05-11 Skyhawk Therapeutics, Inc. Triazine amino derivatives for treating sca3
JP2025517509A (ja) * 2022-05-23 2025-06-05 バイオヘイブン・セラピューティクス・リミテッド 脊髄小脳失調症を治療する方法
WO2026078657A1 (en) 2024-10-10 2026-04-16 Biohaven Therapeutics Ltd. Prodrugs of riluzole

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
WO1995001782A2 (en) 1993-07-09 1995-01-19 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US5457895A (en) 1993-10-01 1995-10-17 R. P. Scherer Corporation Method of identifying freeze-dried dosage forms
US5837287A (en) 1994-10-28 1998-11-17 R P Scherer Corporation Process for preparing solid pharmaceutical dosage forms
WO1998036738A1 (en) 1997-02-20 1998-08-27 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
ATE323467T1 (de) 1997-07-25 2006-05-15 Alpex Pharma Sa Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
FR2774592B1 (fr) * 1998-02-06 2000-03-17 Rhone Poulenc Rorer Sa Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
US7939105B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US6316029B1 (en) 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US6814978B2 (en) 2000-12-29 2004-11-09 Mcneil-Ppc, Inc. Process for preparing a soft tablet
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
DE60222160T2 (de) 2001-10-12 2008-06-12 Elan Pharma International Ltd., Athlone Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
EP1485296B1 (en) 2002-02-13 2011-07-20 Michael K. Weibel Drug dose - form and method of manufacture
DK1477166T3 (da) * 2003-04-28 2006-12-11 Biofrontera Bioscience Gmbh Anvendelse af riluzoler kombineret med egnede hjælpe- og tilsætningsstoffer til behandling af sygdomme, som er kendetegnet ved en hyperproliferation af keratinocytter, navnlig neurodermitis og psoriasis
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US8158152B2 (en) 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
EP1978939A2 (en) 2005-12-27 2008-10-15 Jubilant Organosys Limited Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxine
EP2170282A4 (en) 2007-06-27 2014-11-05 Hanmi Pharm Ind Co Ltd METHOD FOR PRODUCING A QUICKLY CRUSHING FORMULATION FOR ORAL ADMINISTRATION AND DEVICE FOR PREPARING AND PACKAGING THE FORMULATION
EP2271344A4 (en) * 2008-03-31 2011-04-27 Univ South Florida METHOD FOR TREATING ILLNESS-RELATED ATAXIA AND NON-ATTACHIC IMBALANCE
US8221480B2 (en) 2008-10-31 2012-07-17 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US8414356B2 (en) 2008-10-31 2013-04-09 The Invention Science Fund I, Llc Systems, devices, and methods for making or administering frozen particles
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US10639298B2 (en) * 2015-03-03 2020-05-05 Biohaven Therapeutics Ltd. Prodrugs of riluzole and their method of use

Also Published As

Publication number Publication date
AU2018364749A1 (en) 2020-07-02
US12102618B2 (en) 2024-10-01
AU2018364749B2 (en) 2023-11-09
ZA202002626B (en) 2025-02-26
EP4483956A2 (en) 2025-01-01
BR112020009173A2 (pt) 2020-11-03
AU2018364749C1 (en) 2024-02-15
US20230355592A1 (en) 2023-11-09
IL274532B2 (en) 2024-05-01
HRP20241675T1 (hr) 2025-02-14
EP3706739A1 (en) 2020-09-16
PT4483956T (pt) 2026-03-16
DK3706739T3 (da) 2024-12-02
CN112292127A (zh) 2021-01-29
SG11202004332XA (en) 2020-06-29
RS67956B1 (sr) 2026-04-30
EP4483956A3 (en) 2025-03-19
CA3082096A1 (en) 2019-05-16
MX2023012640A (es) 2023-11-08
RS66277B1 (sr) 2025-01-31
US20210023061A1 (en) 2021-01-28
JP2023175823A (ja) 2023-12-12
EP4696324A2 (en) 2026-02-18
KR20250034521A (ko) 2025-03-11
KR20200103658A (ko) 2020-09-02
EP4699619A3 (en) 2026-05-06
ES2996892T3 (en) 2025-02-13
JP7352542B2 (ja) 2023-09-28
US20230390252A1 (en) 2023-12-07
PH12020550583A1 (en) 2021-05-31
IL274532B1 (en) 2024-01-01
FI3706739T3 (fi) 2024-12-27
EP3706739B1 (en) 2024-10-16
WO2019094851A1 (en) 2019-05-16
SMT202500022T1 (it) 2025-03-12
EP3706739A4 (en) 2021-08-04
HUE070302T2 (hu) 2025-05-28
SMT202600156T1 (it) 2026-05-12
IL274532A (en) 2020-06-30
EP4699619A2 (en) 2026-02-25
DK4483956T3 (da) 2026-03-23
FI4483956T3 (fi) 2026-03-16
SI3706739T1 (sl) 2025-03-31
LT3706739T (lt) 2024-12-27
NZ765220A (en) 2023-11-24
PT3706739T (pt) 2024-12-04
MX2020004678A (es) 2020-08-13
EP4696324A3 (en) 2026-05-06
PL3706739T3 (pl) 2025-03-10
MD3706739T2 (ro) 2025-02-28
EP4483956B1 (en) 2025-12-31
JP2021502392A (ja) 2021-01-28

Similar Documents

Publication Publication Date Title
SMT202600156T1 (it) Troriluzolo per l’uso nel trattamento dell’atassia spinocerebellare
GB201813876D0 (en) Treatment
IL276482A (en) Compounds for pain management
GB201800546D0 (en) Treatment
EP3697914C0 (en) VECTORS FOR TREATMENT OF FRIEDREICH'S AAXIA
ZA201907974B (en) Agent for preventing or treating spinocerebellar ataxia
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
GB201814905D0 (en) Treatment
GB201807079D0 (en) Concept 168
GB201807097D0 (en) Concept 11
GB201807104D0 (en) Concept 30
GB201807131D0 (en) Concept 43
GB201807125D0 (en) Concept 37
GB201807126D0 (en) Concept 364
GB201807124D0 (en) Concept 36
GB201807117D0 (en) Concept 32
GB201807084D0 (en) Concept 33
GB201807127D0 (en) Concept 39
GB201807094D0 (en) Concept 22
GB201807083D0 (en) Concept 29
GB201807121D0 (en) Concept 33
GB201807081D0 (en) Concept 23
GB201807130D0 (en) Concept 42
GB201807093D0 (en) Concept 21
GB201807080D0 (en) Concept 54